BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Berezin AE. Prognostication of clinical outcomes in diabetes mellitus: Emerging role of cardiac biomarkers. Diabetes Metab Syndr 2019;13:995-1003. [PMID: 31336558 DOI: 10.1016/j.dsx.2019.01.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Qiao YY, Hou ZM, Li XM, Guo HL, Wang XH. Diagnosis of Early Left Ventricular Systolic Dysfunction by Layer-Specific Strain Echocardiography in Diabetic Rabbits. Ultrasound Med Biol 2021;47:1528-35. [PMID: 33726899 DOI: 10.1016/j.ultrasmedbio.2021.02.005] [Reference Citation Analysis]
2 Senesi P, Luzi L, Terruzzi I. Adipokines, Myokines, and Cardiokines: The Role of Nutritional Interventions. Int J Mol Sci 2020;21:E8372. [PMID: 33171610 DOI: 10.3390/ijms21218372] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Lebedev DA, Lyasnikova EA, Vasilyeva AA, Vasilyeva EY, Babenko AY, Shlyakhto EV. Molecular biomarker profile of heart failure with mid-range and preserved ejection fraction in patients with type 2 diabetes. Russ J Cardiol 2020;25:3967. [DOI: 10.15829/1560-4071-2020-3967] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
4 Heusler I, Biron-Shental T, Farladansky-Gershnabel S, Pasternak Y, Kidron D, Vulih-Shuitsman I, Einbinder Y, Cohen-Hagai K, Benchetrit S, Zitman-Gal T. Enhanced expression of Galectin-3 in gestational diabetes. Nutr Metab Cardiovasc Dis 2021;31:1791-7. [PMID: 34023181 DOI: 10.1016/j.numecd.2021.03.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Lebedev DA, Lyasnikova EA, Vasilyeva EY, Babenko AY, Shlyakhto EV. Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of Fibrosis. J Diabetes Res 2020;2020:6976153. [PMID: 33224989 DOI: 10.1155/2020/6976153] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Lebedev DA, Lyasnikova EA, Vasilyeva EY, Likhonosov NP, Sitnikova MY, Babenko AY. Association between Markers of Fibrosis and Heart Failure Incidence in Patients with Type 2 Diabetes Mellitus. J Diabetes Res 2021;2021:9589185. [PMID: 34778465 DOI: 10.1155/2021/9589185] [Reference Citation Analysis]
7 Damaskos C, Garmpis N, Kollia P, Mitsiopoulos G, Barlampa D, Drosos A, Patsouras A, Gravvanis N, Antoniou V, Litos A, Diamantis E. Assessing Cardiovascular Risk in Patients with Diabetes: An Update. Curr Cardiol Rev 2020;16:266-74. [PMID: 31713488 DOI: 10.2174/1573403X15666191111123622] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Berezin AE, Berezin AA. Circulating Cardiac Biomarkers in Diabetes Mellitus: A New Dawn for Risk Stratification-A Narrative Review. Diabetes Ther. 2020;11:1271-1291. [PMID: 32430864 DOI: 10.1007/s13300-020-00835-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]